This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

S. ARTHUR BORUCHOFF, M.D.; BERNARD GOLDBERG, M.D.

AMA Arch Ophthalmol. 1955;53(5):718-719.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Myasthenia gravis frequently involves the extraocular muscles. Indeed, eye muscle involvement may be the earliest or the only sign of myasthenia gravis. The following history is presented to portray such a case and to call to the attention of the ophthalmologist a new drug for the diagnosis of myasthenia gravis thus far unknown to the ophthalmologic literature.

REPORT OF A CASE

J. C., a 16-year-old white boy, was first seen at the Outpatient Clinic of the New York Eye and Ear Infirmary on July 30, 1953, complaining of "bloodshot eyes." Visual acuity was recorded at 20/20 O. U. Physical examination revealed bilateral bulbar conjunctival injection with no other abnormalities: Lids, media and fundi were normal. Pupillary reactions were normal. No abnormality of the extraocular musculature was noted. The conjunctivitis cleared rapidly and completely on a local chemotherapeutic regimen. He was next seen on May 5, 1954, at which time he complained . . . [Full Text PDF of this Article]

Author Affiliations
Boston; New York

From the service of Dr. Truman L. Boyes and the Department of Research, New York Eye and Ear Infirmary.

Footnotes
Current address: Institute of Ophthalmology, Judd St., London, W. C. 1, England (Dr. Boruchoff).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?